Invivoscribe Technologies, Inc. aka (TVS)

Form 483 issued March 6, 2017 · San Diego, California

Inspection
Mar 6, 2017
Observations
3
Pages
2
FEI number
3004774989

In short: On March 6, 2017, FDA issued a Form 483 with 3 observations to Invivoscribe Technologies, Inc. aka (TVS) in San Diego, California (FEI 3004774989) after an inspection that ran Mar 6, 2017. The investigators were Freddy D. Tita-Nwa and Theresa Kirkham. Most observations concern management controls and design controls.

At a glance

Management controls and design controls account for 2 of 3 observations.

Management controls1
Design controls1
Production & process controls1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    A quality plan has…

  2. 02

    Procedures for design output have…

  3. 03

    Process control procedures that describe any process controls necessary to ensure conformance to specifications have…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Invivoscribe Technologies, Inc. aka (TVS)?

FDA listed 3 observations on this Form 483, mostly about management controls, design controls and production & process controls. The opening words of each observation are shown on this page.

Who inspected Invivoscribe Technologies, Inc. aka (TVS)?

Freddy D. Tita-Nwa and Theresa Kirkham are named on this Form 483, for the inspection of Mar 6, 2017. Each investigator has a profile showing what they cite most.

When was Invivoscribe Technologies, Inc. aka (TVS) inspected by FDA?

The inspection ran Mar 6, 2017, and the Form 483 is dated March 6, 2017.

How do I get the full Form 483 for Invivoscribe Technologies, Inc. aka (TVS)?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free